10 Eli Lilly supply chain leaders

Of these Eli Lilly supply chain leaders, one is associate vice president for the International BU, two are executive directors, four senior directors and three directors, with work spanning device manufacturing, ATMPs, EMEA logistics, material operations and parenteral planning. Four joined Lilly from Elanco, Mirum Pharmaceuticals, Catalent and MSD, which suits a drug or device maker planning supply for a fast-growing product or staffing supply chain at a new site.

10 professionals1 companyData retrieved October 15, 2026

Professionals to explore

  1. Aaron Fontaine

    LinkedIn

    Experience: Director - Supply Chain & Logistics · Eli Lilly and Company

    $336 per 30-minute call

    Aaron Fontaine has been Director - Supply Chain & Logistics at Eli Lilly and Company since 2023, a role their LinkedIn profile gives as Director - Supply Chain API External Mfg. Fontaine's other Lilly titles include Associate Director - Logistics Workstream Lead (2022–2023), Associate Director - Supply Chain (2019–2022) and Manager - Operations (Parenteral Device Assembly & Packaging) (2016–2019), a fit for external API manufacturing supply questions.

    Is this you? Claim your profile and get paid for calls.

  2. Ana González de Cecilia

    LinkedIn

    Experience: Director Global Supply Chain · Eli Lilly and Company

    $336 per 30-minute call

    ATMPs are tied to the Director Global Supply Chain role Ana González de Cecilia has held at Eli Lilly and Company since 2023, and González de Cecilia describes 25+ years in multinational pharma. Other Lilly titles were Associate Director Global Supply Chain (2015–2023), Associate Consultant Global Supply Chain (2012–2015), Master Scehduler (2011–2012) and Supply Chain Product Leader (2006–2010).

    Is this you? Claim your profile and get paid for calls.

  3. Caroline Walsh

    LinkedIn

    Experience: Former Senior Director of Supply Chain and Logistics -LP1 · Eli Lilly and Company

    $404 per 30-minute call

    Caroline Walsh became Senior Director of Supply Chain and Logistics -LP1 at Eli Lilly and Company in 2024 after Director Of Operations at Elanco (2022–2024). At Elanco, Walsh also held Global Supply Chain Network Leader-External Manufacturing (2021–2022) and Global Supply Chain Network Leader-Internal Manufacturing (2020–2021), useful for comparing internal and external manufacturing networks.

    Is this you? Claim your profile and get paid for calls.

  4. Enrico Bora

    LinkedIn

    Experience: Sr. Director - Supply Chain · Eli Lilly and Company

    $404 per 30-minute call

    Site planning and S&OP questions suit Enrico Bora, Sr. Director - Supply Chain at Eli Lilly and Company since October 2025, following Associate Director - Supply Chain Planning & Trasformation (2022–2025). At Catalent, Bora was Inventory and Logistics Manager (2019–2022), Planning Manager (& S&OP Lead) (2017–2019) and Site Procurement Lead (2015–2017).

    Is this you? Claim your profile and get paid for calls.

  5. Gema Gonzalez Martin

    LinkedIn

    Experience: Former Director Global Logistics EMEA · Eli Lilly and Company

    $336 per 30-minute call

    In March 2026, Gema Gonzalez Martin was named Director Global Logistics EMEA at Eli Lilly and Company, after Associate Director Global Logistics EMEA & CIS (2022–2026). Gonzalez Martin's other Lilly titles include Associate Director- Supply Chain planning, master data and PPM (2021–2022) and Planning Manager (2020–2021), which makes Gonzalez Martin the one to ask about EMEA distribution.

    Is this you? Claim your profile and get paid for calls.

  6. Lisa Catauro

    LinkedIn

    Experience: Sr. Director - Supply Chain - Device Manufacturing · Eli Lilly and Company

    $404 per 30-minute call

    Device supply chain is the through line for Lisa Catauro: Sr. Director - Supply Chain - Device Manufacturing at Eli Lilly and Company since September 2024, after Director - Supply Chain - Device Manufacturing (2024) and Associate Director - Supply Chain - Device Manufacturing (2022–2024). Catauro was also Supply Chain Manager (2020–2022) and held Supply Chain Implementation - Devices (2017–2020) at Lilly.

    Is this you? Claim your profile and get paid for calls.

  7. Michael Collins

    LinkedIn

    Experience: Executive Director, Material Operations and Supply Chain · Eli Lilly and Company

    $471 per 30-minute call

    Executive Director, Material Operations and Supply Chain at Eli Lilly and Company since March 2026, Michael Collins was Snr. Director Material Operations and Supply Chain there (2023–2026) and SITE SUPPLY CHAIN LEAD – DIRECTOR at MSD (2018–2023). Collins describes supply chain work in API/DS small molecule and biologics manufacturing, a fit for site material operations questions.

    Is this you? Claim your profile and get paid for calls.

  8. Philippe Perrin

    LinkedIn

    Experience: Associate Vice President - International BU Supply Chain Lead · Eli Lilly and Company

    $471 per 30-minute call

    Since July 2025, Philippe Perrin has been Associate Vice President - International BU Supply Chain Lead at Eli Lilly and Company. Perrin's Lilly titles also include Executive Director - Global Supply Chain Planning (2025), Senior Director - Supply Chain Planning for Parenteral Products (2024–2025), Senior Director - Global Supply Chain (2022–2024) and Senior Director Of Operations (2019–2022), a fit for global and international supply planning questions.

    Is this you? Claim your profile and get paid for calls.

  9. Roy Handoko

    LinkedIn

    Experience: Senior Director of Supply Chain & Logistics · Eli Lilly and Company

    $404 per 30-minute call

    Roy Handoko has been Senior Director of Supply Chain & Logistics at Eli Lilly and Company since March 2025, after Director, Global Supply Chain at Mirum Pharmaceuticals, Inc. (2023–2025). At Takeda, Handoko was Director, Global Supply Planning - BioLife Plasma Services (2021–2023), Associate Director, Supply Chain Planning - Global Supply Chain (2019–2021) and Associate Director, Global S&OP - Immunology Franchise (2017–2019).

    Is this you? Claim your profile and get paid for calls.

  10. Vivian Mercado

    LinkedIn

    Experience: Executive Director Supply Chain and Materials Management · Eli Lilly and Company

    $505 per 30-minute call

    Seamless materials management across the organization is the aim of Vivian Mercado's role as Executive Director Supply Chain and Materials Management at Eli Lilly and Company since July 2025, responsible for leading and optimizing supply chain operations. Mercado's other Lilly titles include Senior Director Business Transformation (2023–2025), Finance Director Corporate Manufacturing (2018–2023) and FINANCIAL CONTROLLER & MATERIALS LEAD (2011–2018).

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For network-wide planning, Philippe Perrin (International BU, earlier global planning and parenteral planning) is the senior pick, with Roy Handoko for S&OP and supply planning learned at Takeda and Mirum. Lisa Catauro and Aaron Fontaine cover device manufacturing and logistics, Michael Collins and Vivian Mercado cover material operations and materials management, Gema Gonzalez Martin covers EMEA logistics, Ana González de Cecilia covers ATMPs, and Caroline Walsh and Enrico Bora bring outside views from Elanco and Catalent.

Questions to take into the conversation

  1. 01How do you allocate tight parenteral and device assembly capacity across markets when demand for a product outruns supply?
  2. 02What changes in materials planning when a pharmaceutical site adds a new product or a second shift of device assembly?
  3. 03How do you set up cold chain logistics for injectable products across EMEA when each country has its own distribution rules?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals